Inoue M - Search Results

1

Activation of NF-kappaB is a novel target of KRAS-induced endometrial carcinogenesis.

Mizumoto Y, Kyo S, Kiyono T, Takakura M, Nakamura M, Maida Y, Mori N, Bono Y, Sakurai H, Inoue M. Mizumoto Y, et al. Among authors: inoue m. Clin Cancer Res. 2011 Mar 15;17(6):1341-50. doi: 10.1158/1078-0432.CCR-10-2291. Clin Cancer Res. 2011. PMID: 21411444

2

Is the telomerase assay useful for screening of endometrial lesions?

Maida Y, Kyo S, Kanaya T, Wang Z, Tanaka M, Yatabe N, Nakamura M, Inoue M. Maida Y, et al. Among authors: inoue m. Int J Cancer. 2002 Aug 20;100(6):714-8. doi: 10.1002/ijc.10543. Int J Cancer. 2002. PMID: 12209612

3

Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis.

Mizumoto Y, Kyo S, Mori N, Sakaguchi J, Ohno S, Maida Y, Hashimoto M, Takakura M, Inoue M. Mizumoto Y, et al. Among authors: inoue m. Cancer Sci. 2007 May;98(5):652-8. doi: 10.1111/j.1349-7006.2007.00445.x. Epub 2007 Mar 27. Cancer Sci. 2007. PMID: 17388789 Free PMC article.

4

Concomitant activation of AKT with extracellular-regulated kinase 1/2 occurs independently of PTEN or PIK3CA mutations in endometrial cancer and may be associated with favorable prognosiss.

Mori N, Kyo S, Sakaguchi J, Mizumoto Y, Ohno S, Maida Y, Hashimoto M, Takakura M, Inoue M. Mori N, et al. Among authors: inoue m. Cancer Sci. 2007 Dec;98(12):1881-8. doi: 10.1111/j.1349-7006.2007.00630.x. Epub 2007 Oct 9. Cancer Sci. 2007. PMID: 17924977 Free PMC article.

5

Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.

Kyo S, Takakura M, Fujiwara T, Inoue M. Kyo S, et al. Among authors: inoue m. Cancer Sci. 2008 Aug;99(8):1528-38. doi: 10.1111/j.1349-7006.2008.00878.x. Cancer Sci. 2008. PMID: 18754863 Free PMC article. Review.

6

Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.

Kyo S, Sakaguchi J, Kiyono T, Shimizu Y, Maida Y, Mizumoto Y, Mori N, Nakamura M, Takakura M, Miyake K, Sakamoto M, Inoue M. Kyo S, et al. Among authors: inoue m. Clin Cancer Res. 2011 Feb 1;17(3):525-37. doi: 10.1158/1078-0432.CCR-10-1287. Epub 2010 Dec 3. Clin Cancer Res. 2011. PMID: 21131554

7

Stem cells in endometrium and endometrial cancer: accumulating evidence and unresolved questions.

Kyo S, Maida Y, Inoue M. Kyo S, et al. Among authors: inoue m. Cancer Lett. 2011 Sep 28;308(2):123-33. doi: 10.1016/j.canlet.2011.05.015. Epub 2011 Jun 17. Cancer Lett. 2011. PMID: 21683518 Review.

8

Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?

Kyo S, Inoue M. Kyo S, et al. Among authors: inoue m. Oncogene. 2002 Jan 21;21(4):688-97. doi: 10.1038/sj.onc.1205163. Oncogene. 2002. PMID: 11850797 Review.

9

Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.

Wang Z, Kyo S, Maida Y, Takakura M, Tanaka M, Yatabe N, Kanaya T, Nakamura M, Koike K, Hisamoto K, Ohmichi M, Inoue M. Wang Z, et al. Among authors: inoue m. Oncogene. 2002 May 16;21(22):3517-24. doi: 10.1038/sj.onc.1205463. Oncogene. 2002. PMID: 12032853

10

Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.

Maida Y, Kyo S, Kanaya T, Wang Z, Yatabe N, Tanaka M, Nakamura M, Ohmichi M, Gotoh N, Murakami S, Inoue M. Maida Y, et al. Among authors: inoue m. Oncogene. 2002 Jun 13;21(26):4071-9. doi: 10.1038/sj.onc.1205509. Oncogene. 2002. PMID: 12037663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,657 results

Search Page

Filters